Pieter Gaillard | Founder, 2-BBB Medicines & Founder and CEO, Eyesiu Medicines

Pieter Gaillard graduated as a neuroscientist at Utrecht University in the Netherlands and obtained a PhD in pharmacology from Leiden University in 2000, after which he founded 2-BBB and successfully conducted six rounds of equity investments, ranging from seed to series C venture capital, as well as numerous non-dilutive credits and grants, and led a major restructuring phase of the company. During this tenure, Pieter either invented or licensed-in the patents held by the company from a Taiwanese research institute, and led the company through the discovery and (pre)clinical phases of drug development. Subsequently, he licensed-out the company’s brain cancer program to a Danish company, established a joint venture in Taiwan around the acute MS relapse program, and co-created a German company focused on treating inherited retinal degenerative diseases.